Drug or treatment

Zipalertinib clinical trials

• 2Clinical trials
• 24Countries

All recruiting trials (2)

• Zipalertinib vs placebo after surgery for uncommon EGFR-mutant NSCLC

  This study tests whether zipalertinib can help people with early-stage, surgically removed NSCLC that has uncommon EGFR mutations-by comparing it to placebo.

  Recruiting at 108 sites Phase 3 Taiho Oncology, Inc. · Anchorage, Alaska and 252 other locations · NCT07128199

• Evaluating zipalertinib for advanced lung cancer with specific EGFR mutations

  This study is testing a new drug called zipalertinib to see if it can help people with advanced lung cancer that has specific genetic mutations and who have few other treatment options.

  Recruiting at 69 sites Phase 2 Taiho Oncology, Inc. · Birmingham, Alabama and 79 other locations · NCT05967689

Quick answers

How many clinical trials of Zipalertinib are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in Australia (2 trials), Canada (2 trials), France (2 trials), Germany (2 trials), Hong Kong (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →